Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Restarti | Power & Utilities | 47.5% | 57th pct | 89 |
| Medikal Teknologi | Power & Utilities | 37.8% | 53rd pct | 89 |
| CEBEP | Power & Utilities | 6.2% | 29th pct | 89 |
| Komunaluri Meurneoba | Power & Utilities | 5.1% | 28th pct | 89 |
| Medikal Saport and Tech… | Power & Utilities | — | no FY data | 89 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Restarti | Komunaluri Meurneoba | Medikal Teknologi | CEBEP | Medikal Saport and Tech… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 79.0% | 93.8% | 100.0% | 92.8% | — |
| EBITDA Margin | 47.5% | 5.1% | 37.8% | 6.2% | — |
| EBITDAR | 1,656 | 165 | 1,062 | 61 | — |
| EBITDAR Margin | 48.6% | 5.1% | 38.2% | 7.0% | — |
| EBIT Margin | 44.6% | 2.9% | 37.8% | 5.1% | — |
| Net Profit Margin | 72.4% | 2.9% | 31.3% | 5.1% | — |
| Operating Expense % of Sales | 31.6% | 88.7% | 62.2% | 86.6% | — |
| Returns | |||||
| Return on Assets (ROA) | 44.2% | 17.1% | 34.0% | 4.2% | — |
| Return on Equity (ROE) | 93.1% | 18.1% | 48.1% | N/A | — |
| ROIC [EBIT / Invested Capital] | 36.6% | 20.0% | 49.9% | N/A | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 36.0% | 0.0% | 26.0% | 1.0% | — |
| Debt-to-Equity | 0.76x | 0.00x | 0.37x | -0.10x | — |
| Debt-to-EBITDA | 1.24x | 0.00x | 0.63x | 0.20x | — |
| Equity-to-Assets | 47.5% | 94.5% | 70.8% | -10.3% | — |
| Net Debt | 1,502 | -49 | 292 | -38 | — |
| Cash & Equivalents | 506 | 49 | 374 | 49 | — |
| Total Debt | 2,009 | N/A | 666 | 11 | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.65x | 0.00x | 0.91x | 0.25x | — |
| Quick Ratio | 0.65x | 0.00x | 0.91x | 0.25x | — |
| Cash Ratio | 0.18x | 1.60x | 0.50x | 0.14x | — |
| Total Current Assets | 1,853 | 0 | 682 | 87 | — |
| Total Current Liabilities | 2,835 | 31 | 746 | 344 | — |
| Inventory | N/A | N/A | N/A | N/A | — |
| Trade Receivables | 328 | 40 | 682 | 23 | — |
| Trade Payables | 700 | N/A | 80 | 59 | — |
| Net Working Capital | -982 | -31 | -64 | -257 | — |
| Net Working Capital % of Revenue | -28.8% | -0.9% | -2.3% | -29.2% | — |
| Trade Working Capital | -372 | 40 | 601 | -37 | — |
| Trade Working Capital % of Revenue | -10.9% | 1.2% | 21.7% | -4.2% | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | N/A | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | — |
| Receivables Turnover | 10.39x | 80.51x | 4.07x | 39.07x | — |
| Days Sales Outstanding (DSO) | 35.1 | 4.5 | 89.6 | 9.3 | — |
| Payables Turnover | 1.02x | N/A | N/A | 1.07x | — |
| Days Payable Outstanding (DPO) | 357.2 | N/A | N/A | 340.0 | — |
| Cash Conversion Cycle | -322.1 days | 4.5 days | 89.6 days | -330.7 days | — |
| Asset Turnover | 0.61x | 5.84x | 1.09x | 0.82x | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | N/A | 32 | 2,776 | 35 | — |
| Free Cash Flow (OCF − Capex proxy) | N/A | 32 | 2,776 | 35 | — |
| Cash Conversion (OCF / EBITDA) | N/A | 19.1% | 264.5% | 64.2% | — |
| Dividends Declared | N/A | N/A | N/A | N/A | — |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | — |